| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:01 -0700 |
| HMDB ID |
HMDB00175 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Inosinic acid |
| Description |
Inosinic acid is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Inosinic acid is a nucleotide present in muscle and other tissues. It is formed by the deamination of AMP and when hydrolysed produces inosine. Inosinic acid is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine. (Wikipedia). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 5'-IMP
- 5'-Inosinate
- 5'-Inosine monophosphate
- 5'-Inosinic acid
- IMP
- Inosine 5'-monophosphate
- Inosine 5'-phosphate
- Inosine Monophosphate
- Inosine-5'-monophosphate
|
| Chemical Formula |
C10H13N4O8P |
| Average Molecular Weight |
348.206 |
| Monoisotopic Molecular Weight |
348.047099924 |
| IUPAC Name |
{[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-6,9-dihydro-1H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic acid |
| Traditional IUPAC Name |
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid |
| CAS Registry Number |
131-99-7 |
| SMILES |
O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=CNC2=O |
| InChI Identifier |
InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 |
| InChI Key |
GRSZFWQUAKGDAV-KQYNXXCUSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Nucleosides, Nucleotides, and Analogues |
| Class |
Purine Nucleotides |
| Sub Class |
Purine Ribonucleotides |
| Other Descriptors |
- Aromatic Heteropolycyclic Compounds
- inosine phosphate(ChEBI)
- purine ribonucleoside 5'-monophosphate(ChEBI)
|
| Substituents |
- 1,2 Diol
- 1 Phosphoribosyl Imidazole
- Glycosyl Compound
- Hypoxanthine
- Imidazole
- Imidazopyrimidine
- Monosaccharide Phosphate
- N Glycosyl Compound
- Organic Hypophosphite
- Organic Phosphite
- Oxolane
- Pentose Monosaccharide
- Phosphoric Acid Ester
- Purine
- Purinone
- Pyrimidine
- Pyrimidone
- Saccharide
- Secondary Alcohol
|
| Direct Parent |
Purine Ribonucleoside Monophosphates |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Alanine and aspartate metabolism
- Component of Purine metabolism
|
| Application |
Not Available |
| Cellular locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Mitochondria
|
| Biofluid Locations |
- Blood
- Cellular Cytoplasm
- Cerebrospinal Fluid (CSF)
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
63.0 +/- 41.0 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cellular Cytoplasm |
Detected and Quantified |
|
10 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
3.19 (0.00 +/- 19.70) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
2.31(0.00-41.40) uM |
Adult (>18 years old) |
Both |
Simple ffebrile seizures |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
2.48 (0.00 +/- 27.20) uM |
Adult (>18 years old) |
Both |
Complex febrile seizures |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Febrile seizures |
- Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M: Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures. Brain Dev. 2000 Oct;22(7):427-31.
Pubmed: 11102727
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021901 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
8264  |
| KEGG Compound ID |
C00130  |
| BioCyc ID |
IMP  |
| BiGG ID |
33960  |
| Wikipedia Link |
Inosinic acid  |
| NuGOwiki Link |
HMDB00175  |
| Metagene Link |
HMDB00175  |
| METLIN ID |
5196  |
| PubChem Compound |
8582  |
| PDB ID |
IMP  |
| ChEBI ID |
17202  |
| References |
| Synthesis Reference |
Park, Yeong Hun; Cho, Gwang Myeong; Baek, Min Ji; Hong, Guk Gi; Lee, Jin Nam. Method for preparing 5'-inosinic acid by using microbe capable of over-expressing purC gene. Repub. Korea (2007), 7pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Green HJ, Grant SM, Phillips SM, Enns DL, Tarnopolsky MA, Sutton JR: Reduced muscle lactate during prolonged exercise following induced plasma volume expansion. Can J Physiol Pharmacol. 1997 Dec;75(12):1280-6.
Pubmed: 9534937
- Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M: Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis. J Child Neurol. 2001 Sep;16(9):704-6.
Pubmed: 11575617
- Pouw EM, Schols AM, van der Vusse GJ, Wouters EF: Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Feb;157(2):453-7.
Pubmed: 9476857
- Castro-Gago M, Cid E, Trabazo S, Pavon P, Camina F, Rodriguez-Segade S, Einis Punal J, Rodriguez-Nunez A: Cerebrospinal fluid purine metabolites and pyrimidine bases after brief febrile convulsions. Epilepsia. 1995 May;36(5):471-4.
Pubmed: 7614924
- Allison AC, Eugui EM: Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant. 1996 Feb;10(1 Pt 2):77-84.
Pubmed: 8680053
- van Hall G, van der Vusse GJ, Soderlund K, Wagenmakers AJ: Deamination of amino acids as a source for ammonia production in human skeletal muscle during prolonged exercise. J Physiol. 1995 Nov 15;489 ( Pt 1):251-61.
Pubmed: 8583409
- McConell G, Snow RJ, Proietto J, Hargreaves M: Muscle metabolism during prolonged exercise in humans: influence of carbohydrate availability. J Appl Physiol. 1999 Sep;87(3):1083-6.
Pubmed: 10484580
- McConell GK, Shinewell J, Stephens TJ, Stathis CG, Canny BJ, Snow RJ: Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans. Med Sci Sports Exerc. 2005 Dec;37(12):2054-61.
Pubmed: 16331129
- Nakayama Y, Kinoshita A, Tomita M: Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition. Theor Biol Med Model. 2005 May 9;2(1):18.
Pubmed: 15882454
- Klupp J, Pfitzmann R, Langrehr JM, Neuhaus P: Indications of mycophenolate mofetil in liver transplantation. Transplantation. 2005 Sep 27;80(1 Suppl):S142-6.
Pubmed: 16286893
- Bangsbo J, Gollnick PD, Graham TE, Juel C, Kiens B, Mizuno M, Saltin B: Anaerobic energy production and O2 deficit-debt relationship during exhaustive exercise in humans. J Physiol. 1990 Mar;422:539-59.
Pubmed: 2352192
- McCauley TG, Hamaguchi N, Stanton M: Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal Biochem. 2003 Aug 15;319(2):244-50.
Pubmed: 12871718
- Rush JW, MacLean DA, Hultman E, Graham TE: Exercise causes branched-chain oxoacid dehydrogenase dephosphorylation but not AMP deaminase binding. J Appl Physiol. 1995 Jun;78(6):2193-200.
Pubmed: 7665417
- McConell GK, Canny BJ, Daddo MC, Nance MJ, Snow RJ: Effect of carbohydrate ingestion on glucose kinetics and muscle metabolism during intense endurance exercise. J Appl Physiol. 2000 Nov;89(5):1690-8.
Pubmed: 11053315
- Swart PJ, Beljaars E, Smit C, Pasma A, Schuitemaker H, Meijer DK: Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA. J Drug Target. 1996;4(2):109-16.
Pubmed: 8894971
- Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC: Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16303-8. Epub 2002 Nov 25.
Pubmed: 12451183
|
| Enzymes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Name: |
Glycogen phosphorylase, liver form
|
| Reactions: |
- [(1->4)-alpha-D-glucosyl]n + phosphate = [(1->4)-alpha-D-glucosyl]n-1 + alpha-D-glucose 1-phosphate [RN:R01821 R06050]
|
| Gene Name: |
PYGL |
| Uniprot ID: |
P06737  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
| Name: |
Glycogen phosphorylase, brain form
|
| Reactions: |
- [(1->4)-alpha-D-glucosyl]n + phosphate = [(1->4)-alpha-D-glucosyl]n-1 + alpha-D-glucose 1-phosphate [RN:R01821 R06050]
|
| Gene Name: |
PYGB |
| Uniprot ID: |
P11216  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
| Name: |
GMP reductase 2
|
| Reactions: |
- inosine 5'-phosphate + NH3 + NADP+ = guanosine 5'-phosphate + NADPH + H+ [RN:R01134]
|
| Gene Name: |
GMPR2 |
| Uniprot ID: |
Q9P2T1  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
GMP reductase 1
|
| Reactions: |
- inosine 5'-phosphate + NH3 + NADP+ = guanosine 5'-phosphate + NADPH + H+ [RN:R01134]
|
| Gene Name: |
GMPR |
| Uniprot ID: |
P36959  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|